Discusses Extended Follow-Up Data From Phase 3 Trial of aglatimagene besadenovec in Localized Prostate Cancer May 15, ...
New survival data from Phase 2a clinical trial evaluating atebimetinib + mGnP in first-line metastatic pancreatic cancer to be presented in an ...
Life Sciences Revenue -- $1.6 million, decreasing 48.4%, with R2 segment revenue mainly impacted by declines in Glacial FX ...
(Palvella or "the Company") (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin ...
Usha Desiraju, PharmD, manager of informatics and clinical content at FDB, and Michael T. Silver, PharmD, clinical ...
Floor rising reshaping revenue cycle shows AI improves denial management and workflow automation at Rush University and Advocate Health.
Digital health transformations are about making sure that what you built works together, at scale, when it matters most.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results